BREAKING NEWS

BREAKING NEWS

GlaxoSmithKline's shingles vaccine gets approval in Canada

Now Reading:

GlaxoSmithKline's shingles vaccine gets approval in Canada

Text size Aa Aa

(Reuters) – Canadian health regulators have approved GlaxoSmithKline’s <GSK.L> key shingles vaccine, the company said on Friday. Shingrix, the British pharma company’s shingles vaccine for people aged 50 years or older, was unanimously recommended for approval by a U.S. Food and Drug Administration (FDA) advisory panel last week. Older people are most at risk of an outbreak of shingles, a painful, often debilitating blistering rash. Shingles is the result of reactivation of the varicella-zoster virus, which causes chickenpox and remains latent in those who have had that disease.

(Reporting By Justin George Varghese in Bengaluru; Editing by Sriraj Kalluvila)
euronews provides breaking news articles from reuters as a service to its readers, but does not edit the articles it publishes. Articles appear on euronews.com for a limited time.